Circulating AQP4-specific auto-antibodies alone can induce neuromyelitis optica spectrum disorder in the rat
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
It is well established that the binding of pathogenic aquaporin-4 (AQP4)-specific autoantibodies to astrocytes may initiate a cascade of events culminating in the destruction of these cells and in the formation of large tissue-destructive lesions typical for patients with neuromyelitis optica spectrum disorders (NMOSD). To date, not a single experimental study has shown that the systemic presence of the antibody alone can induce any damage to the central nervous system (CNS), while pathological studies on brains of NMOSD patients suggested that there might be ways for antibody entry and subsequent tissue damage. Here, we systemically applied a highly pathogenic, monoclonal antibody with high affinity to AQP4 over prolonged period of time to rats, and show that AQP4-abs can enter the CNS on their own, via circumventricular organs and meningeal or parenchymal blood vessels, that these antibodies initiate the formation of radically different lesions with AQP4 loss, depending on their mode and site of entry, and that lesion formation is much more efficient in the presence of encephalitogenic T-cell responses. We further demonstrate that the established tissue-destructive lesions trigger the formation of additional lesions by short and far reaching effects on blood vessels and their branches, and that AQP4-abs have profound effects on the AQP4 expression in peripheral tissues which counter-act possible titer loss by antibody absorption outside the CNS. Cumulatively, these data indicate that directly induced pathological changes caused by AQP4-abs inside and outside the CNS are efficient drivers of disease evolution in seropositive organisms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
Wingerchuk, D. M., Banwell, B., Bennett, J. L., Cabre, P., Carroll, W., Chitnis, T., de Seze, J., Fujihara, K., Greenberg, B., Jacob, A., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001729 · Cited by 4,649
Self-citationAstrocyte-derived VEGF-A drives blood-brain barrier disruption in CNS inflammatory disease
Argaw, A. T., Asp, L., Zhang, J., Navrazhina, K., Pham, T., Mariani, J. N., Mahase, S., Dutta, D. J., Seto, J., Kramer, E. G., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60842 · Cited by 733
Jarius, S., Paul, F., Franciotta, D., Ruprecht, K., Ringelstein, M., Bergamaschi, R., Rommer, P., Kleiter, I., Stich, O., Reuss, R., et al. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.03.038 · Cited by 361
Varrin‐Doyer, M., Spencer, C. M., Schulze‐Topphoff, U., Nelson, P. A., Stroud, R. M., C. Cree, B. A., & Zamvil, S. S. (2012) · Annals of Neurology · doi:10.1002/ana.23651 · Cited by 341
Neuromyelitis optica unique area postrema lesions: Nausea, vomiting, and pathogenic implications
Popescu, B. F. G., Lennon, V. A., Parisi, J. E., Howe, C. L., Weigand, S. D., Cabrera-Gómez, J. A., Newell, K., Mandler, R. N., Pittock, S. J., Weinshenker, B. G., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e318214332c · Cited by 296 · cited 1×
“However, some pathological studies indicated that there may be ways, how antibodies can be directly pathogenic, and that the area postrema [37] or the blood–cerebrospinal fluid (CSF) barrier [9] might be primary entry sites for NMO-IgG into the CNS.”
BackgroundPathogenic T cell responses against aquaporin 4
Pohl, M., Fischer, M.-T., Mader, S., Schanda, K., Kitic, M., Sharma, R., Wimmer, I., Misu, T., Fujihara, K., Reindl, M., et al. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0824-0 · Cited by 98
Self-citationAquaporin 4-specific T cells and NMO-IgG cause primary retinal damage in experimental NMO/SD
Zeka, B., Hastermann, M., Kaufmann, N., Schanda, K., Pende, M., Misu, T., Rommer, P., Fujihara, K., Nakashima, I., Dahle, C., et al. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0355-y · Cited by 65
Self-citationT-cell responses to distinct AQP4 peptides in patients with neuromyelitis optica (NMO)
Vaknin-Dembinsky, A., Brill, L., Kassis, I., Petrou, P., Ovadia, H., Ben-Hur, T., Abramsky, O., & Karussis, D. (2016) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2015.12.004 · Cited by 39
Deletional tolerance prevents AQP4‐directed autoimmunity in mice
Vogel, A., Knier, B., Lammens, K., Kalluri, S. R., Kuhlmann, T., Bennett, J. L., & Korn, T. (2017) · European Journal of Immunology · doi:10.1002/eji.201646855 · Cited by 34
Cited by
Jarius, S., Paul, F., Weinshenker, B. G., Levy, M., Kim, H. J., & Wildemann, B. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0214-9 · Cited by 478
B cells in autoimmune and neurodegenerative central nervous system diseases
Sabatino, J. J., Pröbstel, A.-K., & Zamvil, S. S. (2019) · Nature Reviews Neuroscience · doi:10.1038/s41583-019-0233-2 · Cited by 343
Autoantibodies in neurological disease
Prüss, H. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-021-00543-w · Cited by 319
Aquaporin-4 Water Channel in the Brain and Its Implication for Health and Disease
Mader, S., & Brimberg, L. (2019) · Cells · doi:10.3390/cells8020090 · Cited by 293
Role of B Cells in Multiple Sclerosis and Related Disorders
Comi, G., Bar‐Or, A., Lassmann, H., Uccelli, A., Hartung, H., Montalban, X., Sørensen, P. S., Hohlfeld, R., Hauser, S. L., & Expert Panel of the 27th Annual Meeting of the European Charcot Foundation (2021) · Annals of Neurology · doi:10.1002/ana.25927 · Cited by 283
Self-citationGAD antibodies in neurological disorders — insights and challenges
Graus, F., Saiz, A., & Dalmau, J. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-0359-x · Cited by 249
Deletional tolerance prevents AQP4‐directed autoimmunity in mice
Vogel, A., Knier, B., Lammens, K., Kalluri, S. R., Kuhlmann, T., Bennett, J. L., & Korn, T. (2017) · European Journal of Immunology · doi:10.1002/eji.201646855 · Cited by 34
Hofer, L. S., Ramberger, M., Gredler, V., Pescoller, A. S., Rostásy, K., Sospedra, M., Hegen, H., Berger, T., Lutterotti, A., & Reindl, M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01188 · Cited by 30
“The exact relevance of T-cell independent pathogenicity of a high affinity rodent monoclonal AQP4-Ab (12) remains to be determined, as serum AQP4-Ab in human NMOSD patients are polyclonal, with a wide range of affinities and often much lower antibody titers (9, 10, 13–15).”
BackgroundSelf-citationYick, L.-W., Ma, O. K.-F., Chan, E. Y.-Y., Yau, K. X., Kwan, J. S.-C., & Chan, K.-H. (2023) · JCI Insight · doi:10.1172/jci.insight.161003 · Cited by 21
Metadata
- Authors
- Hillebrand, S., Schanda, K., Nigritinou, M., Tsymala, I., Böhm, D., Peschl, P., Takai, Y., Fujihara, K., Nakashima, I., Misu, T., Reindl, M., Lassmann, H., & Bradl, M.
- Venue
- Acta Neuropathologica
- Published
- 2018-12-18
- Volume
- 137
- Issue
- 3
- Pages
- 467-485
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- OpenAlex
- W2903751956
- Cited by
- 90
- References
- 9
- FWCI
- 7.07
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.